PILOT STUDY ON THE EFFECTIVENESS OF CHOLINE ALFOSCERATE IN THE UNDER THRESHOLD DEPRESSION OF THE ELDERLY - n.a.

Overview

No summary available.

Registry

who.int

Start Date

October 18, 2021

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional clinical trial of medicinal product

Sex

All

Sponsor

•1\.Age \= 65 years
•2\.From 2 to 4 depressive symptoms present for at least two weeks prior to enrollment (Judd et al., 1994\)
•3\.Mini\-Mental State Examination (MMSE) score \= 24
•4\.Montreal Cognitive Assessment (MOCA) score \< 26
•5\.Patients able to understand and sign informed consent
•6\.Informed consent signature
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1\.2 Adults (18\-64 years) no
•F.1\.2\.1 Number of subjects for this age range

•1\.Any contraindication to treatment or intolerance to choline alfoscerate
•2\.Diagnosis of Major Depressive Episode or Dysthymia
•3\.Diagnosis of Schizophrenia or other psychotic disorders, Bipolar Disorder or Dementia
•4\.Alcohol / drug / substance abuse or dependence
•5\.Severe organic disease (eg major surgery, metastatic cancer, stroke, severe neurological disorder, myocardial infarction, chronic heart failure)
•6\.Treatment with antidepressants or psychotherapy within 2 weeks prior to recruitment
•7\.Any condition which, in the opinion of the investigator, might put the patient at risk by participation in this study
•8\.Patients involved in other clinical trials